Publication | Open Access

Universal screening at age 1–2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis

Family MedicineLipid DisorderCost-utility AnalysisHealth PolicyHealth EconomicsCancer ScreeningFamilial HypercholesterolaemiaInherited Metabolic DiseaseGenetic EpidemiologyAge 1–2Disease Risk AssessmentDyslipidemiaPublic HealthMedicineEpidemiology